Article Details
Retrieved on: 2024-05-29 10:54:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Soliris, developed by AstraZeneca (AZN)-owned Alexion Pharmaceuticals, is approved for the same treatment indications. In patients with paroxysmal ...
Article found on: www.morningstar.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here